Psychoeducation of Parents to Children With FASD (NorFASDPEdu)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05686473 |
Recruitment Status :
Not yet recruiting
First Posted : January 17, 2023
Last Update Posted : April 19, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Fetal Alcohol Spectrum Disorders Behavior Problem Adaptive Behavior Learning Disorders | Behavioral: Program of psychoeducation of parents and professionals | Not Applicable |
The main aim of this research project is to evaluate the effects of a standardized intervention program for parents and professionals working with children and adolescents with FASD. Focus will be on care-persons' knowledge and skills and psychoeducation with regard to improved handling of behavioral problems and deficits in self-regulation due to FASD.
To achieve this aim objectives will be:
- to collect and analyse data on family empowerment, parenting skills and stress before and after participation in the intervention program.
- to collect and analyse data on the child's behavior and deficits in self-regulation before and after participation in the intervention program.
- to collect and analyse data on professionals' knowledge of FASD before and after participation in the intervention program.
The current study hypothesizes that caregivers who understand and view their children's behavior from a neurodevelopmental perspective are more likely to feel competence, use antecedent strategies, and thereby reduce child problem behavior and improve functional outcome (Fig. 2). The investigators hypothesize that participation in this program will improve parental empowerment and child self-regulation and behavior compared with baseline assessments.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 75 participants |
Allocation: | N/A |
Intervention Model: | Sequential Assignment |
Intervention Model Description: | Assessments with the evaluation measures will be performed at referral to Regional competence centre/inclusion to study (baseline), at admission to the centre 4-5 months later (pre-intervention), and 4-5 months after finishing program (post-intervention). The period between baseline and pre-intervention will be regarded as a control period, in contrast to the intervention period. |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Evaluation of a Treatment Program Based on Psychoeducation of Parents of Children and Adolescents With Fetal Alcohol Spectrum Disorder (FASD) |
Estimated Study Start Date : | August 2024 |
Estimated Primary Completion Date : | March 2025 |
Estimated Study Completion Date : | June 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: Patient group
Single arm study. The family with child with FASD will act as its own control in the period before intervention starts.
|
Behavioral: Program of psychoeducation of parents and professionals
The program consists of a standardized manual-based treatment package as an easily accessible treatment tool for use by professionals in the specialist health services, who have treatment responsibilities for children diagnosed with FASD in Norway. The intervention program will last for about 2 months and includes eight sessions, including six digitally based, interactive psychoeducational sessions. Topics will be:
|
- The Children's Global Assessment Scale (CGAS) [ Time Frame: up to 10 months ]To evaluate effects of the intervention program well-known standardized, validated measures will be used. Primary outcome measure for the child will be The Children's Global Assessment Scale, which is a numeric scale used by mental health clinicians to rate the general functioning of youths under the age of 18. The scale targets the number of behavioral problems and the frequency of their occurrence.The child or young person is given a single score between 1 and 100. Higher score means better functioning.
- The Family Empowerment Scale (FES) [ Time Frame: up to 10 months ]Primary outcome measure for parents will be The Family Empowerment Scale to evaluate the magnitude of empowerment in the parent-child system. FES is a 34-item rating scale where the participants rate each item on a 5-point Likert-type rating scale. Scores will range between 34 and 170 points. Increasing scores indicate a positive significance regarding family empowerment.
- The Eyberg Child Behavior Inventory (ECBI) [ Time Frame: up to 10 months ]In addition, several well-known secondary measures will be used to evaluate additional effects of program. The ECBI questionnaire will be used to evaluate the number of behavioral problems and the frequency of their occurrence before and after the intervention program. ECBI provides a list of 36 problem behaviors commonly reported by parents. The inventory assesses behavior on two dimensions: 1) the frequency of the behavior; 2) whether parents consider it a problem. The frequency ratings range from 1 (never) to 7 (always), and are summed up to arrive at an overall problem behavior Intensity Score, ranging from 36 to 252. Higher score means more behavioral problems.
- The Social Responsiveness Scale, Second Edition (SRS-2) [ Time Frame: up to 10 months ]The SRS-2 questionnaire will be used to evaluate the severity of social impairment and lack of flexibility in children and adolescents before and after participation in the intervention program. Each domain's T-scores are organized by gender and respondent age, with each domain having varied but similar ranges of possible scores from 32 points-114 points. All T-scores have a mean of 50 points with a standard deviation of 10 points. Higher score means more deficits in social interaction.
- The Behavior Rating Inventory of Executive Function, Second Edition (BRIEF-2) [ Time Frame: up to 10 months ]The BRIEF-2 will be used to evaluate any change in executive functions after participation. Norms tables give T-scores, percentiles, and 90% confidence intervals for four developmental age groups, by gender. Three broad indexes are calculated (Behavior Regulation, Emotion Regulation, and Cognitive Regulation). Higher score means worse outcome.
- The Parenting Stress Index (PSI) [ Time Frame: up to 10 months ]The PSI questionnaire will be used to evaluate parental stress and load before and after participation in the program.The PSI yields a total score, three domain scores, and 15 subscales. Higher raw scores indicate higher levels of stress.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 2 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
All children and adolescents (age 2,5-18 years) referred to the Regional Competence Centre for children with prenatal alcohol exposure in Arendal, Norway will be invited to participate in the current research project.
Inclusion criteria:
- Valid information about alcohol exposure in fetal life. Exceptions to this inclusion criterion are children who have been adopted and with dysmorphic features that are consistent with full Fetal Alcohol Syndrome.
Exclusion Criteria:
- Children with known genetic syndromes, progressive brain and neuromuscular diseases or major sensory defects (blindness or deafness).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05686473
Contact: Anne Cecilie Tveiten, PhD student | +47-370-75750 | Anne.Cecilie.Tveiten@sshf.no | |
Contact: Gro CC Løhaugen, PhD | +47-370-75750 | Gro.lohaugen@sshf.no |
Norway | |
Sørlandet Hospital | |
Arendal, Norway, 4809 | |
Contact: Jon S Skranes, Dr med 99390285 jon.skranes@sshf.no |
Principal Investigator: | Jon S Skranes, Dr Med | Sørlandet Hospital HF |
Responsible Party: | Sorlandet Hospital HF |
ClinicalTrials.gov Identifier: | NCT05686473 |
Other Study ID Numbers: |
NorFASDstudy1 |
First Posted: | January 17, 2023 Key Record Dates |
Last Update Posted: | April 19, 2024 |
Last Verified: | January 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
FASD Psychoeducation Parenting Information program |
Learning Disabilities Fetal Alcohol Spectrum Disorders Problem Behavior Behavioral Symptoms Fetal Diseases Pregnancy Complications Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Alcohol-Induced Disorders |
Alcohol-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Communication Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Neurodevelopmental Disorders Mental Disorders |